This invention relates to a pharmaceutical composition comprising at least two immune checkpoint inhibitors, at least one cytotoxic or cytostatic chemotherapeutic drug. This invention also relates to a method of treating a tumor or a cancer in a patient comprising administering to a patient in need thereof the pharmaceutical composition in an amount effective to treat the tumor or cancer, and optionally a step of ablating at least a portion of the tumor or cancer.
